2 events found.
Video Education Session
Featured
Intravenous Immune Globulin (IVIg) – A newly approved therapeutic option for the treatment of adult dermatomyositis
MSU Zoom Video Session Video session using ZoomLearn about Octapharma’s IVIg therapy and the results of the landmark Progress in Dermatomyositis (ProDERM) study. The successful ProDERM Study resulted in the first and only FDA-approved IVIg therapy for DM in adults. MSU and Octapharma USA are proud to co-sponsor this exciting educational program with Dr. Rohit Aggarwal.
Free
Featured
The VALOR Study – New Clinical Research Opportunity for Dermatomyositis
MSU Zoom Video Session Video session using ZoomPlease join us for a webinar about the new VALOR study. The purpose of the VALOR Study is to learn more about the effectiveness and safety of the investigational medication brepocitinib in adults living with dermatomyositis.
